NewcelX NCEL
NASDAQ NCEL
$2.88 +0.02 (+0.59%)
As of: Nov 11, 2026 · 10:05 AM EST

NewcelX (NCEL) Common Equity (2019 - 2026)

Updated

NewcelX's Common Equity was $6.04 million in Q2 2026, compared with -$15.8 million a year earlier.

Analysis

NewcelX (NCEL) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at NewcelX came in at $7.25 million.

  • In earlier years, Common Equity was -$8 million in FY2024, -$1.2 million in FY2023, $111,000 in FY2022 (-79.5%) and $542,388 in FY2021.
  • Quarterly Common Equity has moved between -$15.8 million (Q2 2025) and $7.25 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 81.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -4.58 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 51.81 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 13.04 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 89.30 Bn
10 NewcelX 13.72 Mn 7.06 Mn - 6.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.04 Mn
Dec 31, 2025 7.25 Mn
Jun 30, 2025 -15.80 Mn
Dec 31, 2024 -8.00 Mn
Jun 30, 2024 -9.27 Mn
Dec 31, 2023 -1.20 Mn
Jun 30, 2023 -4.29 Mn
Dec 31, 2022 111,000.00
Jun 30, 2022 -4.04 Mn
Dec 31, 2021 542,388.00
Jun 30, 2021 4.25 Mn
Dec 31, 2020 -8.98 Mn
Dec 31, 2019 -6.17 Mn
API Access

NewcelX Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NCEL&period=max&api_key=YOUR_API_KEY